Form 8.3 - Steris Corporation


FORM 8.3



Rule 8.3 of the Takeover Code (the “Code”)


(a) Full name of discloser:   Millennium International Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

  Steris Corporation
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

  6 October 2015
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”


If YES, specify which:

Synergy Health Plc


If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:




  Interests   Short positions
  Number   %   Number   %
(1) Relevant securities owned and/or controlled:   143,994   0.240   312,431   0.521
(2) Cash-settled derivatives:           155,000   0.259
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:                


  143,994   0.240   467,431   0.780

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  


Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security   Purchase/sale   Number of securities   Price per unit (USD)
US8591521005   Purchase   500   65.01
US8591521005   Purchase   333   65.03
US8591521005   Purchase   768   65.04
US8591521005   Purchase   100   65.07
US8591521005   Purchase   300   65.08
US8591521005   Purchase   6000   65.12
US8591521005   Purchase   3000   65.13
US8591521005   Purchase   700   65.14
US8591521005   Purchase   2889   65.15
US8591521005   Purchase   200   65.16
US8591521005   Purchase   1457   65.17
US8591521005   Purchase   2494   65.18
US8591521005   Purchase   4674   65.19
US8591521005   Purchase   1400   65.20
US8591521005   Purchase   300   65.21
US8591521005   Purchase   400   65.22
US8591521005   Purchase   99   65.23
US8591521005   Purchase   100   65.26
US8591521005   Purchase   400   65.27
US8591521005   Purchase   100   65.28
US8591521005   Purchase   200   65.29
US8591521005   Purchase   100   65.35
US8591521005   Purchase   100   65.74
US8591521005   Purchase   100   65.81
US8591521005   Purchase   100   65.83
US8591521005   Purchase   100   65.96
US8591521005   Purchase   800   66.00
US8591521005   Purchase   200   66.05
US8591521005   Purchase   200   66.10
US8591521005   Purchase   100   66.11
US8591521005   Purchase   100   66.14
US8591521005   Purchase   609   66.19
US8591521005   Purchase   300   66.25
US8591521005   Purchase   100   66.30
US8591521005   Sale   400   64.97
US8591521005   Sale   100   64.98
US8591521005   Sale   4   64.99
US8591521005   Sale   800   65.01
US8591521005   Sale   233   65.03
US8591521005   Sale   200   65.04
US8591521005   Sale   340   65.05
US8591521005   Sale   500   65.06
US8591521005   Sale   180   65.07
US8591521005   Sale   617   65.08
US8591521005   Sale   400   65.09
US8591521005   Sale   700   65.10
US8591521005   Sale   1601   65.11
US8591521005   Sale   965   65.12
US8591521005   Sale   1532   65.13
US8591521005   Sale   1672   65.14
US8591521005   Sale   513   65.15
US8591521005   Sale   785   65.16
US8591521005   Sale   3100   65.17
US8591521005   Sale   1452   65.18
US8591521005   Sale   3330   65.19
US8591521005   Sale   801   65.20
US8591521005   Sale   1002   65.21
US8591521005   Sale   704   65.22
US8591521005   Sale   1095   65.23
US8591521005   Sale   1305   65.24
US8591521005   Sale   300   65.25
US8591521005   Sale   106   65.26
US8591521005   Sale   500   65.28
US8591521005   Sale   231   65.29
US8591521005   Sale   500   65.30
US8591521005   Sale   100   65.31
US8591521005   Sale   100   65.35
US8591521005   Sale   100   65.73
US8591521005   Sale   6   65.74
US8591521005   Sale   200   65.76
US8591521005   Sale   99   65.78
US8591521005   Sale   1   65.79
US8591521005   Sale   200   65.80
US8591521005   Sale   205   65.90
US8591521005   Sale   100   65.91
US8591521005   Sale   300   65.94
US8591521005   Sale   100   65.97
US8591521005   Sale   400   66.00
US8591521005   Sale   100   66.03
US8591521005   Sale   100   66.04
US8591521005   Sale   87   66.27
US8591521005   Sale   100   66.30
US8591521005   Sale   200   66.32
US8591521005   Sale   200   66.36

(b) Cash-settled derivative transactions

Class of relevant security   Product description

e.g. CFD

  Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

  Number of reference securities   Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security   Product description e.g. call option   Writing, purchasing, selling, varying etc.   Number of securities to which option relates   Exercise price per unit   Type

e.g. American, European etc.

  Expiry date   Option money paid/ received per unit

(ii) Exercise

Class of relevant security   Product description

e.g. call option

  Exercising/ exercised against   Number of securities   Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security   Nature of dealing

e.g. subscription, conversion

  Details   Price per unit (if applicable)


(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”


(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”


(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?   NO
Date of disclosure:   7 October 2015
Contact name:   Milos Naumovic
Telephone number:   +44 203 650 8203

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at

Category Code: RET
Sequence Number: 488480
Time of Receipt (offset from UTC): 20151007T152053+0100


Millennium Partners, L.P.


Millennium Partners, L.P.